BIODESIX INCBDSXEarnings & Financial Report
Nasdaq
NextMar 31, 2026
BDSX Q3 2025 Key Financial Metrics
Revenue
$21.8M
Gross Profit
N/A
Operating Profit
$-7.1M
Net Profit
$-8.7M
Gross Margin
N/A
Operating Margin
-32.4%
Net Margin
-40.0%
YoY Growth
19.9%
EPS
$-1.16
Financial Flow
BIODESIX INC Q3 2025 Financial Summary
BIODESIX INC reported revenue of $21.8M for Q3 2025, with a net profit of $-8.7M (-40.0% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $21.8M |
|---|---|
| Net Profit | $-8.7M |
| Gross Margin | N/A |
| Operating Margin | -32.4% |
| Report Period | Q3 2025 |
BIODESIX INC Annual Revenue by Year
BIODESIX INC annual revenue history includes year-by-year totals (for example, 2024 revenue was $71.3M).
| Year | Annual Revenue |
|---|---|
| 2024 | $71.3M |
| 2023 | $49.1M |
| 2022 | $38.2M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.7M | $14.8M | $17.9M | $18.2M | $20.4M | $18.0M | $20.0M | $21.8M |
| YoY Growth | 52.7% | 63.6% | 51.0% | 34.5% | 39.3% | 21.2% | 11.7% | 19.9% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $99.1M | $87.2M | $115.8M | $102.7M | $97.2M | $86.2M | $87.7M | $88.7M |
| Liabilities | $94.5M | $92.7M | $79.6M | $74.9M | $76.4M | $75.2M | $86.6M | $90.4M |
| Equity | $4.6M | $-5.5M | $36.3M | $27.9M | $20.9M | $11.1M | $1.1M | $-1.7M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-12.3M | $-15.3M | $-18.6M | $-10.7M | $-4.1M | $-8.6M | $-6.6M | $-8.9M |